1st November, 2019
Labetalol 100mg/20ml Ampoules
The launch of Labetalol IV by Bowmed Ibisqus has brought necessary reinforcement of the UK supply chain for this critical hospital medicine following periods of shortage during 2019.
This is the first product to be brought to the UK market following our new distribution partnership with S.A.L.F. S.p.A. For over 90 years S.A.L.F. have brought essential medicines across a variety of therapeutic forms to the Italian market and we are excited to develop this new European partnership in the coming months and years.
This product follows the original and familiar product format of 100mg/20ml and is packaged in clear glass ampoules for ease of visual examination. The ampoules have been affixed with labels in a longitudinal manner so that the product details can be viewed in the same field of vision, in accordance with MHRA Best Practice guidelines. In addition, we have been able to avoid a plastic tray component in favour of a secure recyclable cardboard tray.
The product has been listed with AAH under order code LAB0138K. If you would like to discuss a pricing arrangement or stock availability for Labetalol IV or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us